The aim of Neu<sup>3</sup>ca is to study cognitive ageing, to characterize “accelerated cognitive ageing” as a clinical phenomenon in [epilepsy](/background/epilepsy), and to obtain biomarkers that allow alerting for the development of pathological time courses of ageing.